PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients.
de Souza JA, Menin A, Lima LO, Smiderle L, Hutz MH, Van Der Sand CR, Van Der Sand LC, Ferreira ME, Pires RC, Almeida S, Fiegenbaum M.
de Souza JA, et al. Among authors: almeida s.
Clin Biochem. 2015 Nov;48(16-17):1039-44. doi: 10.1016/j.clinbiochem.2015.06.009. Epub 2015 Jun 12.
Clin Biochem. 2015.
PMID: 26079344